These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19643070)

  • 21. Oxidative modulation of soluble guanylate cyclase by manganese.
    Braughler JM
    Biochim Biophys Acta; 1980 Nov; 616(1):94-104. PubMed ID: 6108132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of purified soluble guanylate cyclase activated by nitric oxide and sodium nitroprusside.
    Lewicki JA; Brandwein HJ; Mittal CK; Arnold WP; Murad F
    J Cyclic Nucleotide Res; 1982; 8(1):17-25. PubMed ID: 6127356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement for heme in the activation of purified guanylate cyclase by nitric oxide.
    Craven PA; DeRubertis FR
    Biochim Biophys Acta; 1983 Jun; 745(3):310-21. PubMed ID: 6134553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of sulfhydryl groups in the oxidative modulation of particulate lung guanylate cyclase by nitric oxide and N-methyl-N'nitro-N-nitrosoguanidine.
    Braughler JM
    Biochem Pharmacol; 1982 Apr; 31(7):1239-44. PubMed ID: 6124254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of liver guanylate cyclase by paraquat: possible role of superoxide anion.
    Vesely DL; Watson B; Levey GS
    J Pharmacol Exp Ther; 1979 Apr; 209(1):162-4. PubMed ID: 34715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble guanylate cyclase activation by nitric oxide and its reversal. Involvement of sulfhydryl group oxidation and reduction.
    Braughler JM
    Biochem Pharmacol; 1983 Mar; 32(5):811-8. PubMed ID: 6132608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade by N-methylhydroxylamine of activation of guanylate cyclase and elevations of guanosine 3',5'-monophosphate levels in nervous tissues.
    Deguchi T; Saito M; Kono M
    Biochim Biophys Acta; 1978 Nov; 544(1):8-19. PubMed ID: 31192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential alterations in responsiveness in particulate and soluble guanylate cyclases in pregnant guinea pig myometrium.
    Buhimschi IA; San Martin-Clark O; Aguan K; Thompson LP; Weiner CP
    Am J Obstet Gynecol; 2000 Dec; 183(6):1512-9. PubMed ID: 11120520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The stimulation by catecholamines of guanylate cyclase activity in a cell-free system.
    Liang CT; Sacktor B
    J Cyclic Nucleotide Res; 1978 Apr; 4(2):97-111. PubMed ID: 26703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Proof of guanylate cyclase activity in the coronary artery of cattle].
    Busse E
    Acta Biol Med Ger; 1976; 35(12):1595-601. PubMed ID: 17986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung.
    Ignarro LJ; Degnan JN; Baricos WH; Kadowitz PJ; Wolin MS
    Biochim Biophys Acta; 1982 Sep; 718(1):49-59. PubMed ID: 6128034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of guanylate cyclase of rod outer segments of the bovine retina.
    Krishnan N; Fletcher RT; Chader GJ; Krishna G
    Biochim Biophys Acta; 1978 Apr; 523(2):506-15. PubMed ID: 26409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting the activity of guanylate cyclase in lysates of human blood platelets.
    Adams AF; Haslam RJ
    Biochem J; 1978 Jul; 174(1):23-35. PubMed ID: 29607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of guanylate cyclase with the axoneme of retinal rods.
    Fleischman D; Denisevich M; Raveed D; Pannbacker RG
    Biochim Biophys Acta; 1980 Jun; 630(2):176-86. PubMed ID: 6104515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of nitrosoguanidine sensitivity of cerebellar guanylate cyclase induced by acute ethanol administration.
    Kuriyama K; Yoshikawa K; Kanmori K
    Jpn J Pharmacol; 1982 Apr; 32(2):323-8. PubMed ID: 6124646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desensitization to nitroglycerin in vascular smooth muscle from rat and human.
    Waldman SA; Rapoport RM; Ginsburg R; Murad F
    Biochem Pharmacol; 1986 Oct; 35(20):3525-31. PubMed ID: 2876710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.
    Arnold WP; Mittal CK; Katsuki S; Murad F
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3203-7. PubMed ID: 20623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial guanylate cyclase: properties of the enzyme and effects of cholinergic agonists in vitro.
    Limbird LE; Lefkowitz RJ
    Biochim Biophys Acta; 1975 Jan; 377(1):186-96. PubMed ID: 235292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Particulate guanylate cyclase of skeletal muscle: effects of Ca2+ and other divalent cations on enzyme activity.
    Levine SN; Steiner AL; Earp HS; Meissner G
    Biochim Biophys Acta; 1979 Jan; 566(1):171-82. PubMed ID: 31938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of the guanylate cyclase of the social amoeba Dictyostelium discoideum.
    Padh H; Brenner M
    Arch Biochem Biophys; 1984 Feb; 229(1):73-80. PubMed ID: 6142695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.